Literature DB >> 2139078

Molecular heterogeneity of murine mast cell Fc gamma receptors.

M Benhamou1, C Bonnerot, W H Fridman, M Daëron.   

Abstract

Fc gamma R expressed by mouse mast cells were characterized as functional binding sites, as membrane proteins, and as products of the two genes known to encode murine Fc gamma RII. Peritoneal mast cells, bone marrow-derived mast cells (BMMC), and the mastocytoma cells P815 were found to bear trypsin-resistant, 2.4G2+, low-affinity receptors binding mouse monoclonal IgG1, IgG2a, and IgG2b, i.e., Fc gamma RII. BMMC and P815 Fc gamma RII appeared as heterogeneous membrane proteins that, when deglycosylated, had m.w. corresponding to those of the three known products of the alpha and beta Fc gamma R genes, and differed by their respective contents in BMMC and P815 cells. Heterogeneous Fc gamma R transcripts were also found in BMMC and in P815 RNA. P815 cells contained alpha, beta 1, and beta 2 Fc gamma R transcripts, whereas BMMC contained alpha and beta 1 Fc gamma R transcripts. These data disclose an unexpected molecular heterogeneity of murine mast cell Fc gamma R. Although they appear as a single population of receptors when viewed by external ligands, mast cell Fc gamma R comprise three Fc gamma RII subtypes, encoded by the three known transcripts of the alpha and beta Fc gamma R genes, and differing by their intracytoplasmic portion. The different distributions of Fc gamma RII transcripts and corresponding Fc gamma RII subtypes in different types of mast cells may be determinant for triggering the various biologic activities of these cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139078

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Experimental infection with Trypanosoma cruzi increases the population of CD8(+), but not CD4(+), immunoglobulin G Fc receptor-positive T lymphocytes.

Authors:  Andrea Henriques-Pons; Bianca P Olivieri; Gabriel M Oliveira; Marc Daëron; Tania C de Araújo-Jorge
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors.

Authors:  M Daëron; O Malbec; S Latour; M Arock; W H Fridman
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

3.  Role of Fc gamma receptors in triggering host cell activation and cytokine release by Borrelia burgdorferi.

Authors:  J Talkington; S P Nickell
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

4.  Suppression of IgE B cells and IgE binding to Fc(epsilon)RI by gene therapy with single-chain anti-IgE.

Authors:  Takayuki Ota; Miyo Aoki-Ota; Bao Hoa Duong; David Nemazee
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

5.  Fc gamma RI-mediated activation of human mast cells promotes survival and induction of the pro-survival gene Bfl-1.

Authors:  Mats Karlberg; Zou Xiang; Gunnar Nilsson
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

Review 6.  Regulation of the expression of murine alpha- and beta-Fc gamma R genes.

Authors:  M Daëron
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

7.  Anti-(human LFA-1) monoclonal antibodies bind P815 murine tumour cells.

Authors:  M J Palisson; A Altemeyer; I Moosbrugger; S Warter; G Hauptmann; P Bischoff
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

8.  The Fyn-STAT5 Pathway: A New Frontier in IgE- and IgG-Mediated Mast Cell Signaling.

Authors:  Nicholas A Pullen; Yves T Falanga; Johanna K Morales; John J Ryan
Journal:  Front Immunol       Date:  2012-05-11       Impact factor: 7.561

9.  T cell receptor-independent CD2 signal transduction in FcR+ cells.

Authors:  A R Arulanandam; S Koyasu; E L Reinherz
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

10.  Mast cells and company.

Authors:  Friederike Jönsson; Marc Daëron
Journal:  Front Immunol       Date:  2012-02-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.